A detailed history of Sandia Investment Management LP transactions in Nuvalent, Inc. stock. As of the latest transaction made, Sandia Investment Management LP holds 5,000 shares of NUVL stock, worth $419,250. This represents 3.8% of its overall portfolio holdings.

Number of Shares
5,000
Holding current value
$419,250
% of portfolio
3.8%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$67.44 - $112.17 $337,200 - $560,850
5,000 New
5,000 $511,000
Q1 2023

May 15, 2023

SELL
$25.42 - $33.52 $63,550 - $83,800
-2,500 Reduced 38.46%
4,000 $104,000
Q4 2022

Feb 14, 2023

BUY
$18.46 - $36.37 $119,990 - $236,404
6,500 New
6,500 $193,000

Others Institutions Holding NUVL

About Nuvalent, Inc.


  • Ticker NUVL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,977,800
  • Market Cap $3.6B
  • Description
  • Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...
More about NUVL
Track This Portfolio

Track Sandia Investment Management LP Portfolio

Follow Sandia Investment Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandia Investment Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Sandia Investment Management LP with notifications on news.